BridgeMD
New treatment option for Out-Of-Hospital Cardiac Arrest
Official title REmote COnditioning in Out-of-Hospital Cardiac Arrest
ClinicalTrials.gov ID: NCT06306625
What this study is testing
- What it's testing
- Out-of-Hospital Cardiac Arrest remains a major public health problem, resulting in high mortality largely related to multiple organ failure and poor neurological outcomes due to brain anoxia. The pathophysiology of organ dysfunction after resuscitated out-of-hospital cardiac arrest involves ischemia-reperfusion processes.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Age between 18 and 80 years old
- Out-of-hospital cardiac arrest, whatever the initial cardiac rhythm (shockable or non-shockable) or the duration of no-flow and low-flow,
- Presence of a witness who may or may not have started cardiopulmonary resuscitation, or patient seen alive in the 30 minutes prior to the cardiac...
- Hospitalisation in critical care (intensive care unit or cardiac intensive care unit) for less than 3 hours,
- Informed consent obtained from a close relative (exceptionally from the patient himself if his condition permits) or, failing this, use of the...
You likely can't join if
- Traumatic cardiac arrest
- Patient on extracorporeal circulatory assistance
- Cardiac arrest for which continuation of resuscitation does not appear justified (unavoidable death, terminal stage of an irreversible disease, etc.)
- Contraindication of the use of brachial cuff on both arms (arteriovenous fistula, lymphoedema or severe peripheral vascular pathology, unstable...
- Pregnant, parturient, or breast-feeding women
- Patients deprived of their liberty by a judicial or administrative decision,
See the full eligibility criteria
- Age between 18 and 80 years old
- Out-of-hospital cardiac arrest, whatever the initial cardiac rhythm (shockable or non-shockable) or the duration of no-flow and low-flow,
- Presence of a witness who may or may not have started cardiopulmonary resuscitation, or patient seen alive in the 30 minutes prior to the cardiac arrest,
- Hospitalisation in critical care (intensive care unit or cardiac intensive care unit) for less than 3 hours,
- Informed consent obtained from a close relative (exceptionally from the patient himself if his condition permits) or, failing this, use of the emergency procedure by the investigator.
- Traumatic cardiac arrest
- Patient on extracorporeal circulatory assistance
- Cardiac arrest for which continuation of resuscitation does not appear justified (unavoidable death, terminal stage of an irreversible disease, etc.)
- Contraindication of the use of brachial cuff on both arms (arteriovenous fistula, lymphoedema or severe peripheral vascular pathology, unstable humeral fracture, continuous infusion into an upper limb vein of an...
- Pregnant, parturient, or breast-feeding women
- Patients deprived of their liberty by a judicial or administrative decision,
- Patients under legal protection (guardianship, curatorship),
- Patient not affiliated to a social security scheme or beneficiary of a similar scheme,
- Previous inclusion in the study,
- Subject participating in other treatment research that may interfere with the present study according to the investigator's judgement or that includes an exclusion period still in progress at inclusion
The study team makes the final eligibility decision.
Where it's taking place
- Bron, France
- Clermont-Ferrand, France
- Dijon, France
- La Tronche, France
- Lyon, France
- Marseille, France
- Montpellier, France
- Nîmes, France
- Paris, France
- Pierre-Bénite, France
- Saint-Priest-en-Jarez, France
- Villefranche-sur-Saône, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bron, France; Clermont-Ferrand, France; Dijon, France; La Tronche, France; Lyon, France; Marseille, France and 6 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.